# MasterMediTech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mastermeditech-co

- Industry: Pharmaceuticals
- Headquarters: Seoul, South Korea
- Website: www.mastermeditech.co.kr
- Total disclosed funding: $7.1M
- Latest round: Series A (Mar 29, 2021)
- Investors on record: 4

## About

Based in Seoul, South Korea, and founded in 2019, MasterMeditech using chemical technology develops new drugs. As of 2023, the company is headed by its CEO Bongjin LEE. In March 2021, the firm raised KRW 8 billion in Series A funding from investors CP Partners, Huons Medicare, Samho Green Investment, and Spring Camp.

The company specialized in drug discovery using protein structure and medicinal chemistry technology.

## Funding rounds

- Series A, Mar 29, 2021, $7.1M — Samho Green Investment, Spring Camp, Huons Meditech, CP Partners

## Investors

- Samho Green Investment (https://capitalatlas.ai/funds/samho-green-investment) — Series A
- Spring Camp (https://capitalatlas.ai/funds/spring-camp) — Series A
- Huons Meditech — Series A
- CP Partners (https://capitalatlas.ai/funds/cp-partners) — Series A